SEARCH

SEARCH BY CITATION

References

  • Abouzeid, H. E., Kassem, A. M., Abdel Wahab, A. H., El-Mezayen, H. A., Sharad, H., & Abdel Rahman, S. (2011) Promoter hypermethylation of RASSF1A, MGMT, and HIC-1 genes in benign and malignant colorectal tumors. Tumour Biol 32, 845852.
  • Akino, K., Toyota, M., Suzuki, H., Mita, H., Sasaki, Y., Ohe-Toyota, M., Issa, J. P., Hinoda, Y., Imai, K., & Tokino, T. (2005) The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer. Gastroenterology 129, 156169.
  • Amin, K. S. & Banerjee, P. P. (2012) The cellular functions of RASSF1A and its inactivation in prostate cancer. J Carcinog 11, 3.
  • Chen, S. P., Wu, C. C., Huang, S. Y., Kang, J. C., Chiu, S. C., Yang, K. L., & Pang, C. Y. (2012) Beta-catenin and K-ras mutations and RASSF1A promoter methylation in Taiwanese colorectal cancer patients. Genet Test Mol Biomarkers 16, 12771281.
  • Cleary, S. P., Cotterchio, M., Shi, E., Gallinger, S., & Harper, P. (2010) Cigarette smoking, genetic variants in carcinogen-metabolizing enzymes, and colorectal cancer risk. Am J Epidemiol 172, 10001014.
  • Cooper, K., Squires, H., Carroll, C., Papaioannou, D., Booth, A., Logan, R. F., Maguire, C., Hind, D., & Tappenden, P. (2010) Chemoprevention of colorectal cancer: systematic review and economic evaluation. Health Technol Assess 14, 1206.
  • Dammann, R., Li, C., Yoon, J. H., Chin, P. L., Bates, S., & Pfeifer, G. P. (2000) Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 25, 315319.
  • Dunlop, M. G., Tenesa, A., Farrington, S. M., Ballereau, S., Brewster, D. H., Koessler, T., Pharoah, P., Schafmayer, C., Hampe, J., Volzke, H., Chang-Claude, J., Hoffmeister, M., Brenner, H., Von Holst, S., Picelli, S., Lindblom, A., Jenkins, M. A., Hopper, J. L., Casey, G., Duggan, D., Newcomb, P. A., Abuli, A., Bessa, X., Ruiz-Ponte, C., Castellvi-Bel, S., Niittymaki, I., Tuupanen, S., Karhu, A., Aaltonen, L., Zanke, B., Hudson, T., Gallinger, S., Barclay, E., Martin, L., Gorman, M., Carvajal-Carmona, L., Walther, A., Kerr, D., Lubbe, S., Broderick, P., Chandler, I., Pittman, A., Penegar, S., Campbell, H., Tomlinson, I., & Houlston, R. S. (2013) Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals. Gut 62, 871881.
  • Ferlay, J., Shin, H. R., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127, 28932917.
  • Fernandes, M. S., Carneiro, F., Oliveira, C., & Seruca, R. (2013) Colorectal cancer and RASSF family–a special emphasis on RASSF1A. Int J Cancer 132, 251258.
  • Fu, J., Zhang, Y. J., & Zhang, D. J. (2010) Transcription,expression and promotor hypermethylation of RASSF1A gene in human colon carcinoma tissue. Prog Mod Biomed 10, 45134516.
  • Hu, J. L., Chen, Y., Liu, S., Chen, S. L., & Jiang, M. J. (2010) Relationship of RASSF1A promoter methylation with expressions of Cyclin D1 and P53 in colorectal cancer. Chin J Cancer Biotherapy 17, 444449.
  • Huxley, R. R., Ansary-Moghaddam, A., Clifton, P., Czernichow, S., Parr, C. L., & Woodward, M. (2009) The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer 125, 171180.
  • Kang, H. J., Kim, E. J., Kim, B. G., You, C. H., Lee, S. Y., Kim, D. I., & Hong, Y. S. (2012) Quantitative analysis of cancer-associated gene methylation connected to risk factors in Korean colorectal cancer patients. J Prev Med Public Health 45, 251258.
  • Kimura, N., Moribe, T., Iizuka, N., Miura, T., Tamatsukuri, S., Ishitsuka, H., Hamamoto, Y., & Oka, M. (2009) Rapid and quantitative detection of CpG-methylation status using TaqMan PCR combined with methyl-binding-domain polypeptide. Clin Biochem 42, 11131122.
  • Lao, V. V. & Grady, W. M. (2011) Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol 8, 686700.
  • Li, C. J., Yan, L., Wen, X. G., & Luo, J. B. (2011) Expression and significance RASSF1A methylation and mRNA in colorectal cancer. Shandong Med J 51, 8788.
  • Miladi-Abdennadher, I., Abdelmaksoud-Damak, R., Ayadi, L., Khabir, A., Frikha, F., Kallel, L., Amouri, A., Frikha, M., Sellami-Boudawara, T., Gargouri, A., & Mokdad-Gargouri, R. (2010) Hypermethylation of RARbeta2 correlates with high COX-2 expression and poor prognosis in patients with colorectal carcinoma. Tumour Biol 31, 503511.
  • Miranda, E., Destro, A., Malesci, A., Balladore, E., Bianchi, P., Baryshnikova, E., Franchi, G., Morenghi, E., Laghi, L., Gennari, L., & Roncalli, M. (2006) Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer. Brit J Cancer 95, 11011107.
  • Oliveira, C., Velho, S., Domingo, E., Preto, A., Hofstra, R. M., Hamelin, R., Yamamoto, H., Seruca, R., & Schwartz Jr., S. (2005) Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer. Oncogene 24, 76307634.
  • Pan, Z. G., Kashuba, V. I., Liu, X. Q., Shao, J. Y., Zhang, R. H., Jiang, J. H., Guo, C., Zabarovsky, E., Ernberg, I., & Zeng, Y. X. (2005) High frequency somatic mutations in RASSF1A in nasopharyngeal carcinoma. Cancer Biol Ther 4, 11161122.
  • Peters, J. L., Sutton, A. J., Jones, D. R., Abrams, K. R., & Rushton, L. (2006) Comparison of two methods to detect publication bias in meta-analysis. JAMA 295, 676680.
  • Sakamoto, N, Terai, T, Ajioka, Y, Abe, S, Kobayasi, O, Hirai, S, Hino, O., Watanabe, H., Sato, N. T., & Fujii, H. (2004) Frequent hypermethylation of RASSF1A in early flat-type colorectal tumors. Oncogene 23, 89008907.
  • Sinha, R., Hussain, S., Mehrotra, R., Kumar, R. S., Kumar, K., Pande, P., Doval, D. C., Basir, S. F., & Bharadwaj, M. (2013) Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation: indicators of tumor staging and metastasis in adenocarcinomatous sporadic colorectal cancer in Indian population. PLoS One 8, e60142.
  • Stang, A. (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25, 603605.
  • Tommasi, S., Pinto, R., Petriella, D., Pilato, B., Lacalamita, R., Santini, D., Zito, F., Colucci, G., Paradiso, A., & Silvestris, N. (2011) Oncosuppressor methylation: a possible key role in colon metastatic progression. J Cell Physiol 226, 19341939.
  • Van Engeland, M., Roemen, G. M., Brink, M., Pachen, M. M., Weijenberg, M. P., De Bruine, A. P., Arends, J. W., Van Den Brandt, P. A., De Goeij, A. F., & Herman, J. G. (2002) K-ras mutations and RASSF1A promoter methylation in colorectal cancer. Oncogene 21, 37923795.
  • Wagner, K. J., Cooper, W. N., Grundy, R. G., Caldwell, G., Jones, C., Wadey, R. B., Morton, D., Schofield, P. N., Reik, W., Latif, F., & Maher, E. R. (2002) Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms’ tumour and colorectal cancer. Oncogene 21, 72777282.
  • Wang, X. D., Wang, H. Z., Xu, H., Liang, G. D., Zhang, W., Zhu, B. P., Fang, X. D., & Jiang, H. W. (2011) Clinical significance of RASSF1A promoter methylation in colorectal cancer. Chin J Labor Diagnosis 15, 15381539.
  • Yu, Z. H., Shi, Z. R., Gao, Y., Wang, Y. C., Su, Q. S., Yu, H. J., Liu, C., Lin, Y., & Ma, C. Y. (2011) RASSF1A promoter hypermethylation of serum DNA in gastric and colorectal adenocarcinoma patients. Oncology Progress 9, 555560.
  • Zintzaras, E. & Ioannidis, J. P. (2005) HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics 21, 36723673.